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ABSTRACT  
More advanced visualization tools are needed to assist with the analyses and interpretation of 
human metabolomics data, which are rapidly increasing in quantity and complexity. Using a 
dataset of several hundred bioactive lipid metabolites profiled in a cohort of ~1500 individuals 
sampled from a population-based community study, we performed a comprehensive set of 
association analyses relating all metabolites with eight demographic and cardiometabolic traits 
and outcomes. We then compared existing graphical approaches with an adapted ‘rain plot’ 
approach to display the results of these analyses. The rain plot combines the features of a 
raindrop plot and a parallel heatmap approach to succinctly convey, in a single visualization, the 
results of relating complex metabolomics data with multiple phenotypes. This approach 
complements existing tools, particularly by facilitating comparisons between individual 
metabolites and across a range of pre-specified clinical outcomes. We anticipate that this single 
visualization technique may be further extended and applied to alternate study designs using 
different types of molecular phenotyping data. 
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INTRODUCTION 
 
Advancements in metabolomics technologies have enabled the generation of large-scale 
metabolomics measures in human studies.1,2 Accordingly, newer generation visualization tools 
are needed to assist with the analyses and interpretation of these increasingly high-dimensional 
and complex data sets. Several resources now offer a variety of techniques for visualizing 
metabolomics data structure and exploring the inter-relations between individual and groups of 
metabolites.3-16 The most commonly used methods for visually analyzing and representing 
associations between metabolites and outcomes are borrowed from conventional statistics and 
other biological fields.3,4 Creating visualizations that can facilitate the interpretation of multi-level 
analyses, including information regarding associations among multiple metabolites and multiple 
outcomes, continues to pose a special challenge. We have therefore developed a visualization 
technique that expands upon existing approaches to enable the display of results from multiple 
simultaneous analyses relating metabolites and clinical phenotypes.  
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METHODS AND RESULTS 
 
For development of these visualization methods, we used a metabolomics dataset comprising 
>500 bioactive lipids assayed by high resolution LC-MS in a subset of the Framingham Heart 
Study offspring cohort (N=1447 participants; see Supplement for details).17 Given the biological 
importance of lipid metabolites with respect to cardiometabolic disease traits, we used multiple 
regression models to relate the extended panel of metabolites with clinical traits as part of staged 
analyses that were conducted in a pre-specified order (Fig. 1a). Manhattan plots display P values 
for each model run, and highlight statistically significant associations of all metabolites with each 
outcome (Fig. 1b). Although colored dots can provide information regarding the directionality of 
associations, along with corresponding P value, the magnitude of each association is not easily 
conveyed. This issue can be addressed using parallel heatmaps, a commonly applied 
visualization approach for high-dimensional ‘omics’ data, wherein one plot depicts magnitude of 
effect and directionality (e.g. beta coefficients) while the other depicts corresponding statistical 
significance (e.g. P value) (Fig. 1c). Although such an approach allows for global visualization of 
data, discerning clear patterns within or between metabolites can be difficult, especially across 
multiple heatmap plots and with increasing data set size.  
 
To overcome this limitation, we combined the visualization concepts offered by the conventional 
heatmap and previously reported raindrop plot methods18 to develop a single technique for 
visualizing the results of relating multiple metabolites with multiple outcomes. As seen in the 
adapted ‘rain plot’ shown in Fig. 1d, directionality and magnitude of estimates for the top 50 
metabolites associated with the selected outcomes are displayed using a color fill scale and the 
corresponding significance level is represented by size of the circle (i.e. rain ‘droplet’). The 
metabolites are ordered top to bottom by overall smallest to largest global P value for associations 
across all clinical traits and outcomes.  
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The rain plot visualization emphasizes two types of comparisons: (1) between-outcome results, 
and (2) between-metabolite results. For between-outcome comparisons, visually scanning for 
vertical patterns of large sized or deeply colored droplets (i.e., droplet ‘streams’) serves to 
highlight those outcomes that are the most broadly associated with a given panel of metabolites. 
As shown in Fig. 1d, this particular panel of bioactive lipids appears more globally associated with 
older age, sex, and Framingham Risk Score. A special feature of the rain plot is its emphasis on 
potentially important between-metabolite comparisons. For instance, certain metabolites (i.e. 20 
and 27) are very strongly associated with sex (Fig. 1b-d). For each of these metabolite rows, a 
visual scan from left to right clarifies the relatively lower degrees of association for these 
metabolites with other outcomes of interest. The plot also visually clarifies interesting findings 
between the top-most prioritized metabolites. For instance, Metabolite 1 is positively associated 
with older age, male sex, and greater metabolic as well as cardiovascular disease risk. 
Conversely, Metabolite 2 is associated with lower metabolic risk, but is not significantly associated 
with either age or sex (Fig. 1d). The plot also highlights a finding for Metabolite 3 that distinguishes 
this analyte from Metabolites 1 and 2: while similarly associated with both greater Framingham 
Risk Score and risk for incident cardiovascular disease events, Metabolite 3 is not associated with 
prevalent or incident diabetes (Fig. 1d). In effect, Metabolite 3 appears associated with both 
prevalent and future cardiovascular risk through a biological pathway that is likely distinct from 
diabetes risk. Similar between-metabolite comparisons are possible across the entire plot. The 
code used to create a rain plot and select parameters for data display is provided for the scientific 
community (https://github.com/biodatacore/2017.09-rainplots), and this code may be adapted 
easily for a variety of similar datasets. 
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DISCUSSION 
 
As analytical chemistry methods continue to mature, resulting in larger and more complex 
metabolomics data, there is a growing need for ways to visually understand and interpret the 
relations of these high-dimensional data with multiple outcomes of interest. Using a dataset of 
metabolite measures performed in a population scale cohort, we compared several existing 
visualization techniques (Supplement). In this context, we developed and demonstrate the 
potential utility of a rain plot approach to maximally render the multiple types of information that 
can be derived from the observed relationships between a panel of metabolites and a set of 
clinical traits and outcomes. We anticipate that this approach may be further extended and applied 
to alternate study designs using different types of molecular phenotyping data – as part of the 
ongoing effort to effectively, efficiently, and feasibly convey the results of large-scale, high-
dimensional data analyses.19,20 
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FIGURE LEGEND 
 
Figure 1. Visualization of complex metabolomics data. For studies that involve multiple staged 
experiments or statistical models, several options exist for visualizing analysis results. For a set 
of statistical models (a) performed in a large human study, for example, a Manhattan plot (b) can 
display the degree to which a wide panel of metabolites is associated with different outcomes 
although the magnitude of these associations is not conveyed. Pairing of heatmaps can display 
magnitude as well as directionality and significance for each metabolite association (c), although 
between-metabolite comparisons of associations across all outcomes is not easily discernible. A 
‘rain plot’ approach (d) combines the information from paired heatmaps into a single plot that 
emphasizes two types of information: (i) between-outcome comparisons, such as the extent to 
which most metabolites in this panel are associated with certain outcomes (e.g. age, sex) more 
than others; and, (ii) between-metabolite comparisons, such as the extent to which certain 
metabolites are associated with an aggregate measure of clinical cardiovascular disease risk (e.g. 
Framingham risk score) with or without concurrent relations to major component risk factors (e.g. 
diabetes risk for Metabolites 3 and 4, compared to for Metabolites 1 and 2). Between-metabolite 
comparisons, in particular, can facilitate identification of potentially important biological 
differences underlying the observed results of relating multiple metabolites to multiple 
phenotypes. 
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SUPPLEMENT 
 
 
SUPPLEMENTAL METHODS 
 
Study Cohort and Design 
We used high-throughput metabolomics data collected from participants of the Framingham Heart 
Study (FHS) offspring cohort. In 1971, the Framingham Offspring Study recruited the children and 
their spouses of the original cohort to participate in a longitudinal epidemiological study.21 All 
participants underwent a history, physical, and laboratory assessment at each study examination 
cycle, approximately every four years. We used a bioactive lipids profiling method with >500 
metabolites in N=2895 participants who attended their eighth examination cycle (2005-2008).17 
For this investigation, we analyzed a randomly selected subset comprising N=1447 individuals 
(mean age 66 [range 40-92] years, 54% women). Informed consent was obtained from all study 
participants and all study protocols were approved by the Institutional Review Boards of Boston 
University, Brigham and Women’s Hospital, and University of California San Diego. 
 
Metabolomics Procedures and Data Processing 
Nontargeted LC-MS based metabolomics analysis was performed on all available N=2895 
plasma samples, according to previously described protocols.17 In brief, plasma samples were 
prepared and analyzed using a Thermo Vanquish UPLC coupled to a high resolution Thermo 
QExactive orbitrap mass spectrometer. Metabolites were isolated from plasma using protein 
precipitation with organic solvent followed by solid phase extraction. Extracted metabolites were 
underwent chromatographic separation using reverse phase chromatography whereby samples 
were loaded onto a Phenomenex Kinetex C18 (1.7um, 2.1x100mm) column and eluted using a 7 
minute linear gradient starting with water : acetonitrile : acetic acid (70:30:0.1) and ending with 
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acetonitrile : isopropanol : acetic acid (50:50:0.02). LC was coupled to a high resolution Orbitrap 
mass analyzer with electrospray ionization operating in negative ion mode, with full scan data 
acquisition across a mass range of 225 to 650 m/z. Thermo .raw data files were converted to 32-
bit centroid .mzXML using Msconvert (Proteowizard software suite), and resulting .mzXML files 
were analyzed using Mzmine 2.21, as described.17  
 
Statistical Analyses 
For the present analyses, 16% of analytes had >10% missing values; we replaced missing values 
for metabolites with 0.25 x the minimum observed value for that metabolite, as reported 
previously.22 Metabolite variables were then natural logarithmically transformed and standardized 
(mean=0, SD=1) to facilitate cross-metabolite comparisons. We then performed multivariable 
regression analyses to examine the relation of each metabolite with several clinical traits and 
outcomes, in the following order: age (adjusted for sex), female sex (adjusted for age), body mass 
index (adjusted for age and sex), metabolic syndrome defined according to the NCEP III criteria.23 
(adjusted for age and sex), prevalent diabetes as previously defined24 (adjusted for age and sex), 
incident diabetes assessed at examination cycle 9 as previously defined 24 (adjusted for age, sex, 
body mass index, and fasting glucose at examination cycle 8), Framingham Risk Score25 as a 
measure of prevalent cardiovascular risk assessed at examination cycle 8, and incident hard 
cardiovascular disease [CVD] as defined previously26 (adjusted for Framingham Risk Score at 
exam 8). 
 
Data Visualization 
We displayed the results of these relational analyses using a variety of techniques, including 
Manhattan plots (for one outcome at a time, with results ordered by mass-to-charge [m/z] value), 
bar and scatter plots (for one outcome at a time, with bars representing magnitude and 
directionality of estimates, and scatter dots representing P values), heatmaps (p’s or beta’s only), 
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rain plot (beta’s, p’s, trends across a panel). We created heatmaps and rainplots with metabolites 
both unclustered and clustered based on hierarchical clustering (R hclust function). We combined 
the visualization concepts captured by the conventional heatmap and previously reported raindrop 
plot18 methods to develop a rainplot approach to visualizing metabolomics association analyses 
results. Details regarding the coding schema used to develop the rainplot approach and select 
specific parameters for the type of data displayed, for a given set of outcomes, are provided at: 
https://github.com/biodatacore/2017.09-rainplots. All analyses and data visualizations were 
performed using R v3.4.1and RStudio v1.0.153, and visualizations were developed using 
ggplot2.27 
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SUPPLEMENTAL RESULTS 
 
The study cohort comprised N=1447 individuals (age 66±9 years, 54% women), including 54% 
women who were aged 66±9 years with average body mass index 28±5 kg/m2, Framingham Risk 
Score 9±4 points, 62% metabolic syndrome, and 14% diabetes.  All approaches to visualizing the 
results of association analyses demonstrated a range in the degree to which different metabolites 
were related to the different outcomes of interest. The extent and type of information conveyed 
varied across the visualization techniques, as summarized in Table S1 and detailed below. 
 
The Manhattan plots display P values for each model run, and highlight statistically significant 
associations for all outcomes across all the metabolites analyzed and ordered from left to right 
along the x axis by mass-to-charge ratio (m/z). In the individual plots displayed, select metabolites 
associations appear very significant for almost all outcomes (Figure S1). The marked significance 
of metabolite associations with sex as well as BMI, compared with the other outcomes, is more 
clearly demonstrated when the results for all outcomes are displayed in a faceted plot with a 
shared y axis. The directionality of associations is not conveyed, however, such that it is unclear 
from these plots if the most significant sex associations represent metabolites with elevated 
circulating levels in men versus women. 
 
The bar and scatter plots display both the directionality and magnitude of associations, for each 
outcome, along with P values for the top 50 associated metabolites rank ordered by significance 
from left to right (Figure S2). These plots are rendered separately for each outcome, with variable 
x and y axis limits, although these could be aligned to match within a faceted plot displaying 
results for multiple outcomes. The extent to which the same metabolite is positively or negatively 
associated with different outcomes is not as easily discernible. However, the overall trend of 
generally more positive or more negative associations observed between a given outcome (e.g., 
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age and Framingham Risk Score) and a large panel of metabolites is clearly displayed. 
Exceptions to such trends are also highlighted. For instance, although most of the more significant 
sex-related metabolites are associated with being female (coded as 2) versus male (coded as 1), 
the top sex-related metabolites are associated with being male and the magnitude of these 
estimates is large. 
 
There are several ways to use the heatmap technique to visualize metabolite-phenotype 
associations, with and without clustering. A common approach is to display directionality and 
magnitude of estimates for different outcomes on a color scale, with or without magnitude of 
corresponding P values in a separate parallel plot on a different color scale (Figure S3). While 
the ordering of clinical phenotypes may be pre-specified, the ordering of metabolites may be 
clustered (Figure 4A) or unclustered, and potentially ordered by smallest to largest P value for top 
hits (Figure 4B), m/z ratio (Figure 4C), or by biological pathways if these are known.  
 
As an extension from the heatmap approach to visualizing results for multiple outcomes in relation 
to multiple metabolites, we also developed a rain drop visualization method. As shown in Figure 
S4, directionality and magnitude of estimates for the top 50 metabolites associated with the 
selected outcomes are displayed by color fill scale (red for positive directionality, blue for negative 
directionality, and color shade for effect size) with corresponding P values represented by size of 
the circle (or rain “droplet”). The metabolites are ordered top to bottom by overall smallest to 
larges P value for associations across all clinical traits and outcomes. The figure shows vertical 
patterns featuring more prominent droplet “streams” for certain outcomes (e.g. age, BMI, and 
Framingham Risk Score), that highlight the degree to which this panel of metabolites is generally 
positively associated with older age and greater BMI. The figure also shows horizontal patterns 
of interest, which are potentially important for comparing the extent to which individual metabolites 
(profiled as part of the same MS method or panel of metabolites) are or are not related in the 
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same way with a set of clinical traits. For instance, the first row metabolite is positively associated 
with older age, male sex, and greater metabolic as well as cardiovascular disease risk. By 
contrast, the second row metabolite is associated with lower metabolic risk in the absence of any 
significant relationship with either age or sex. Furthermore, the rain plot highlights a finding for 
the third row metabolite that distinguishes this analyte from the first and second row metabolite. 
This third row metabolite is similarly associated with both greater Framingham Risk Score and 
risk for incident cardiovascular disease events; however, unlike for the first and second row 
metabolites, this third row metabolite is not associated with prevalent or incident diabetes. Thus, 
the rain plot visualization clarifies the analytical results suggesting that the third row metabolite is 
associated with both prevalent and future cardiovascular risk via a biological pathway that is much 
less likely to involve diabetes, when compared to pathways represented by other metabolite 
associations. These types of distinguishing characteristics, seen on a metabolite by metabolite 
basis, are not as easily discernible from the other visualizations. 
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SUPPLEMENTAL FIGURE LEGENDS 
 
Figure S1. Manhattan plots. Panel A shows Manhattan plots displaying the distribution of P 
values for associations between metabolites (ordered by mass-to-charge ratio along the x-axis) 
and each clinical phenotype separately. Panel B shows Manhattan plots for all clinical traits 
combined into a single visualization with a single y-axis displaying a common maximal value to 
facilitate comparisons between results across outcomes. 
 
Figure S2. Bar and scatter plots. Bar and scatter plots display both the beta coefficients and 
corresponding P values for associations between metabolites and different clinical traits or 
outcomes (one per plot) with the order of metabolites ordered left to right from smallest to largest 
P value. Panel A displays results for all analyses, and Panel B displays results for the top 50 
associated metabolites. 
 
Figure S3. Parallel heat maps. Parallel heat maps display beta coefficients (left plot) and 
corresponding P values (right plot) for the top 50 metabolites associated with the clinical traits 
and outcomes listed as column headings. Results are ordered top to bottom by smallest to largest 
P value (Panel A), mass-to-charge ratio (Panel B), and by clustering (Panel C). 
 
Figure S4. Rain plots. Rain plots display the directionality of beta coefficients by color (red for 
positive, blue for negative), the magnitude of effect by color scale (deeper color for larger 
magnitude of effect), the significance of association by circle size (larger circle size for greater 
statistical significance and smaller P value), and the degree to which one or more clinical 
outcomes is associated with multiple metabolites measured using the same method. Results are 
ordered top to bottom by smallest to largest P value (Panel A), mass-to-charge ratio (Panel B), 
and by clustering (Panel C).  
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Table S1. Dimension of information offered by different visualization methods. 
Visualization method 
Significance of 
associations 
with an outcome 
Magnitude and 
directionality of 
associations with 
an outcome 
Clustering 
Significance of 
associations 
with multiple 
outcomes 
Magnitude and 
directionality of 
associations with 
multiple outcomes 
Manhattan plot X   X  
Bar and scatter plots X X    
Heatmap  X X X  
Rain plot X X X X X 
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Figure S1A.  
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Figure S1B.  
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Figure S2A. 
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Figure S2B.  
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Figure S3A. 
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Figure S3B. 
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Figure S3C. 
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Figure S4A.  
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Figure S4B. 
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Figure S4C. 
  
